Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750411 · ClinicalTrials.gov registry record
Severe Asthma Research Program - Wake Forest University
A clinical trial, sponsored by Wake Forest University.
- Completed
- Registry status
- 87
- Enrollment target
NCT01750411 is a clinical trial that has completed, run by Wake Forest University. The registered enrollment target is 87 participants.
The verdict
NCT01750411 has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The mission of SARP is to improve the understanding of severe asthma through the integrated study of the effect of genetics on the clinical and biological features of asthma and to investigate how these change over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2012-12 |
| Est. Completion | 2021-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01750411
The ClinicalTrials.gov registry entry for NCT01750411 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01750411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01750411 about?
NCT01750411 is a clinical study titled "Severe Asthma Research Program - Wake Forest University". The mission of SARP is to improve the understanding of severe asthma through the integrated study of the effect of genetics on the clinical and biological features of asthma and to investigate how these change over time. The ultimate goal of these efforts is to promote better treatments for severe a...
What is the current status of trial NCT01750411?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2012-12. Estimated completion is 2021-01-15.
Who is sponsoring clinical trial NCT01750411?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.